H2R, thanks for posting that chart. I agree that this rapid resubmission is indicative of the trial results finally being close to approval for future FDA submission. That was my take-away, at least, and my hope - I've been burned a few times by CVM over the past decade, so nothing would surprise me here, lol.
Despite all of the noise surrounding the trial results, I can't imagine how complex the trial data must be, given length of run-time, number of patients involved, and the number of sites and countries where the trial was conducted. From this perspective, I think that CT sending the results back for more editing several times is reasonable, if frustrating. I'm sure there are MANY T's to cross and I's to dot. I try to keep this in mind while I wait for things to start moving a little faster...
Best of luck to you, as well.
News 
Market Data 
Discover 
